Related Experiment Video
Updated: Jun 20, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Drug labeling and its impact on patient safety
Alison G Vredenburgh1, Ilene B Zackowitz
1Vredenburgh & Associates, Inc., Human Factors, Safety, and Organizational Consulting, Carlsbad, CA 92008, USA. alisonv@rondrunner.com
Abstract:
Adverse drug events (ADE) are defined as any medication error with significant potential to harm a patient [13]. Often times, ADE occur due to inadequate or ineffective systems of labeling. These ADE often result in mistakes in prescription adherence (compliance) with the prescription instructions. These mistakes are costly and can be deadly. Potential problems with drug labeling can occur in both in-patient and out-patient environments. This paper discusses some of the key issues to consider in drug labeling and its impact on patient safety.
Related Concept Videos
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
FDA Approved Drugs: Changes to Approved Drugs
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmaceutical Poisoning: Potential Scenarios
Dosage Regimen: Individualization
